Alios BioPharma, Inc.

Alios BioPharma, Inc.

Alios BioPharma, Inc.

Overview
Date Founded

2008

Headquarters

260 East Grand Avenue,2nd floor,San Francisco, CA 94080

Type of Company

Private

Employees (Worldwide)

51 - 100

Industries

Pharmaceuticals
Biotechnology

Company Description

Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA.

Website

http://www.aliosbiopharma.com

Contact Data
Trying to get in touch with decision makers at Alios BioPharma, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
Business Wire
January 13, 2021
BioPharma Services Pivots to Provide COVID-19 Testing for Entertainment Industry
Commercial Property Executive
June 10, 2020
BioPharma Relocates US Operations to Metro St. Louis
PR Newswire
June 3, 2020
Global Automotive OS Market Study 2019-2020: Focus on China - Basic Auto OS, Custom-Made Auto OS, ROM Auto OS, and Super Auto APP
Business Wire
June 3, 2020
Global and China Automotive Operating System (OS) Industry Report, 2019-2020 - ResearchAndMarkets.com
PR Newswire
February 11, 2020
Healthpeak Properties(TM) Reports Fourth Quarter and Year Ended 2019 Results

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Scott D. Seiwert

Vice President-Drug Discovery

Debra Bannister

Head-Media Relations

Bruce Bryan

Senior Director-Operations

Derrick Leon

Director of Information Technology

Bruce Connors

Director

Leonid Vides

Marketing Director

Marija Prhavc

Principal

Qingling Zhang

Associate Director

Madhu Sanga

Associate Director

Andreas Jekle

Principal Scientist

Board of Directors
Peter Hirth

Research Scientist at Max Planck Society

Campbell Murray

Managing Director at Novartis Venture Fund

Jens Eckstein

Director & Managing Partner at Action Potential Venture Capital

Heath Lukatch

Partner at TPG Growth LLC

Trending People
The Federal Bureau of Prisons
Federal Prisons On Lockdown Because Of 'Current Events' - npr.org
3M Innovative Properties Co.
U.S. Patents Awarded to Inventors in Pennsylvania (Jan. 16) - Targeted News Service
Boston Scientific Scimed, Inc.
U.S. Patents Awarded to Inventors in Maryland (Jan. 16) - Targeted News Service
Medtronic, Inc.
U.S. Patents Awarded to Inventors in Massachusetts (Jan. 16) - Targeted News Service
Ecolab, Inc.
U.S. Patents Awarded to Inventors in Pennsylvania (Jan. 16) - Targeted News Service
Trending Organizations
The Federal Bureau of Prisons
Federal Prisons On Lockdown Because Of 'Current Events' - npr.org
3M Innovative Properties Co.
U.S. Patents Awarded to Inventors in Pennsylvania (Jan. 16) - Targeted News Service
Boston Scientific Scimed, Inc.
U.S. Patents Awarded to Inventors in Maryland (Jan. 16) - Targeted News Service
Medtronic, Inc.
U.S. Patents Awarded to Inventors in Massachusetts (Jan. 16) - Targeted News Service
Ecolab, Inc.
U.S. Patents Awarded to Inventors in Pennsylvania (Jan. 16) - Targeted News Service
Paths to Alios BioPharma, Inc.
Potential Connections via
Relationship Science
You
Alios BioPharma, Inc.
Recent Transactions
Details Hidden

Johnson & Johnson purchases Alios BioPharma, Inc. from GSK Equity Investments Ltd, Novartis Venture Fund, Roche Ventures, Novo Ventures 1 A/S

Details Hidden

Alios BioPharma, Inc. raised money in a private placement transaction

Details Hidden

Alios BioPharma, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor
Goldman Sachs & Co. LLC

Advised onJohnson & Johnson purchases Alios BioPharma, Inc. from GSK Equity Investments Ltd, Novartis Venture Fund, Roche Ventures, Novo Ventures 1 A/S

Legal Advisor
Latham & Watkins LLP

Advised onJohnson & Johnson purchases Alios BioPharma, Inc. from GSK Equity Investments Ltd, Novartis Venture Fund, Roche Ventures, Novo Ventures 1 A/S

Legal Advisor
Benjamin A. Potter

Advised onJohnson & Johnson purchases Alios BioPharma, Inc. from GSK Equity Investments Ltd, Novartis Venture Fund, Roche Ventures, Novo Ventures 1 A/S

Legal Advisor
Chad G. Rolston

Advised onJohnson & Johnson purchases Alios BioPharma, Inc. from GSK Equity Investments Ltd, Novartis Venture Fund, Roche Ventures, Novo Ventures 1 A/S

Legal Advisor
Grace M. L. Chen

Advised onJohnson & Johnson purchases Alios BioPharma, Inc. from GSK Equity Investments Ltd, Novartis Venture Fund, Roche Ventures, Novo Ventures 1 A/S

Advisors & Consultants
Legal Advisor
Mark V. Roeder

Partner at Latham & Watkins LLP
Non-Profit Donations & Grants
$50K +
2017
Boston University

Investors
Details Hidden
Lawrence M. Blatt

Chief Executive Officer & Director at Aligos Therapeutics, Inc.

Details Hidden
GSK Equity Investments Ltd

SR One invests in companies located in the US and the UK. The firm targets companies operating in the fields of biotechnology. It provides financing for early stage capital requirements.

Details Hidden
Novo Holding A/S

Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation’s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Alios BioPharma, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Alios BioPharma, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Alios BioPharma, Inc..